Wright Medical Group (NASDAQ:WMGI) : The consensus on Wright Medical Group (NASDAQ:WMGI) based on 17 analyst recommendation on the company stock is 1.47, which is interpreted as a Strong Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 12 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 2 analyst believes that the stock is a Buy, which can produce decent returns in the future. 3 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.
Wright Medical Group (NASDAQ:WMGI) : Currently there are 13 street experts covering Wright Medical Group (NASDAQ:WMGI) stock. The most bullish and bearish price target for the stock is $33 and $22 respectively for the short term. The average price target of all the analysts comes to $26.31. The estimated standard deviation from the target is $3.97.
For the current week, the company shares have a recommendation consensus of Buy. Also, Guggenheim Securities initiates coverage on Wright Medical Group (NASDAQ:WMGI). The shares have now been rated Buy by the stock experts at the ratings house. The rating by the firm was issued on June 9, 2016.
Wright Medical Group (NASDAQ:WMGI): stock turned positive on Tuesday. Though the stock opened at $16.35, the bulls momentum made the stock top out at $16.58 level for the day. The stock recorded a low of $16.17 and closed the trading day at $16.27, in the green by 0.81%. The total traded volume for the day was 1,359,267. The stock had closed at $16.14 in the previous days trading.
In an insider trading activity, Walker Jennifer S., officer (SVP, Process Improvement) of Wright Medical Group N.V., unloaded 1,167 shares at an average price of $19.34 on June 2, 2016. The total amount of the transaction was worth $22,570, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Companys business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Companys products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.